Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Journal of Fish Diseases
|
August 16, 2011
Presence and interaction of inflammatory cells in the spleen of Atlantic cod, Gadus morhua L., infected with Francisella noatunensis
M C Gjessing, M Inami, S C Weli, et al.
Leukemia
|
September 14, 2007
Analysis of the exon 12 and 14 mutations of the JAK2 gene in Philadelphia chromosome-positive leukemia
M Inami, H Yamaguchi, S Hasegawa, et al.
Cancer Chemotherapy and Pharmacology
|
June 10, 1998
FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome
Y Naoe, M Inami, S Matsumoto, et al.
Japanese Journal of Cancer Research : Gann
|
December 16, 1998
Different effects of FK317 on multidrug-resistant tumor in vivo and in vitro
Y Naoe, M Inami, S Takagaki, et al.
Anticancer Research
|
May 6, 1998
Effect of FR143430, a novel cytokine suppressive agent, on adenocarcinoma colon26-induced cachexia in mice
N Yamamoto, I Kawamura, F Nishigaki, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
April 1, 1995
FK143, a novel nonsteroidal inhibitor of steroid 5 alpha-reductase: (1) In vitro effects on human and animal prostatic enzymes
J Hirosumi, O Nakayama, T Fagan, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
April 1, 1995
FK143, a novel nonsteroidal inhibitor of steroid 5 alpha-reductase: (2) In vivo effects on rat and dog prostates
J Hirosumi, O Nakayama, N Chida, et al.
Japanese Journal of Cancer Research : Gann
|
March 19, 1999
FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice
Y Naoe, M Inami, S Matsumoto, et al.
Anticancer Research
|
January 11, 2000
Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome induced by colon26 adenocarcinoma in mice
I Kawamura, E Lacey, N Yamamoto, et al.
Epilepsia
|
December 1, 1980
Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan
Y Nakane, T Okuma, R Takahashi, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Journal of Fish Diseases
|
August 16, 2011
Presence and interaction of inflammatory cells in the spleen of Atlantic cod, Gadus morhua L., infected with Francisella noatunensis
M C Gjessing, M Inami, S C Weli, et al.
Leukemia
|
September 14, 2007
Analysis of the exon 12 and 14 mutations of the JAK2 gene in Philadelphia chromosome-positive leukemia
M Inami, H Yamaguchi, S Hasegawa, et al.
Cancer Chemotherapy and Pharmacology
|
June 10, 1998
FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome
Y Naoe, M Inami, S Matsumoto, et al.
Japanese Journal of Cancer Research : Gann
|
December 16, 1998
Different effects of FK317 on multidrug-resistant tumor in vivo and in vitro
Y Naoe, M Inami, S Takagaki, et al.
Anticancer Research
|
May 6, 1998
Effect of FR143430, a novel cytokine suppressive agent, on adenocarcinoma colon26-induced cachexia in mice
N Yamamoto, I Kawamura, F Nishigaki, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
April 1, 1995
FK143, a novel nonsteroidal inhibitor of steroid 5 alpha-reductase: (1) In vitro effects on human and animal prostatic enzymes
J Hirosumi, O Nakayama, T Fagan, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
April 1, 1995
FK143, a novel nonsteroidal inhibitor of steroid 5 alpha-reductase: (2) In vivo effects on rat and dog prostates
J Hirosumi, O Nakayama, N Chida, et al.
Japanese Journal of Cancer Research : Gann
|
March 19, 1999
FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice
Y Naoe, M Inami, S Matsumoto, et al.
Anticancer Research
|
January 11, 2000
Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome induced by colon26 adenocarcinoma in mice
I Kawamura, E Lacey, N Yamamoto, et al.
Epilepsia
|
December 1, 1980
Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan
Y Nakane, T Okuma, R Takahashi, et al.
Page
of 3